SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AD0. A total of 43 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.5%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opti Capital Management, LP | 45,402,000 | $44,828,000 | 4.21% |
| Radcliffe Capital Management, L.P. | 69,010,000 | $67,802,000 | 1.97% |
| Penn Mutual Asset Management | 675 | $672,000 | 1.06% |
| CAMDEN ASSET MANAGEMENT L P /CA | 24,548,000 | $24,118,000 | 0.95% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 38,428,000 | $38,079,000 | 0.87% |
| DeepCurrents Investment Group LLC | 21,155,000 | $20,805,000 | 0.62% |
| SHENKMAN CAPITAL MANAGEMENT INC | 6,813,000 | $6,618,000 | 0.51% |
| OAKTREE CAPITAL MANAGEMENT LP | 22,348,000 | $22,068,000 | 0.31% |
| WOLVERINE ASSET MANAGEMENT LLC | 16,540,000 | $16,325,000 | 0.14% |
| AVIVA PLC | 17,300,000 | $16,926,000 | 0.08% |